🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

“Cari amici, mi spiace non essere più con voi dopo 70 anni assieme” Leggi la lettera di #PieroAngela👉bit.ly/Piero13agosto #13agosto

Mark your calendars for the inaugural “Human Pluripotent Stem Cell-Derived Hematopoiesis” symposium hosted by ISCRM at UW in Seattle. Check out the awesome program below, and DM me or co-organizer @eirinipapapetr1 if you would like to present a poster. iscrm.uw.edu/pluripotent-he…

Immensi 🎉🇮🇹

Just arrived in NOLA for #ASH22 with Sergei Doulatov Laura Baquero Galvis Martina Sarchi Rachel Wellington!

Sergei Doulatov Trainees assembled!

Excited to present our work on SF3B1-mutant #MDS tomorrow! #ASH22

No stem cell, but it'll have to do!

Flying home from #ASH22. 4 days of exciting science and good memories, thanks everyone for such a great time!

✅️Double Doc! Thanks to everyone Sergei Doulatov and twitterless Malcovati group Università di Pavia for making this PhD journey so special!! 👩🏼‍🔬🩸

Looking forward to presenting our work tomorrow afternoon! Can't wait to hear all of the great science, meet old friends and make new connections #ASH23 🩸

Excited to share our study in collaboration with Hai Dang Nguyen, PhD and co-led by Zhiyan (Silvia) Liu and Sayantani Sinha (sayantani sinha) on targeting aberrant R-loop accumulation via PARP1 inhibition in splicing factor (SF)-mutant leukemias in Cancer Research. aacrjournals.org/cancerres/arti…

This week I had such a great experience talking about research and cancer to high school students. Thanks to Fondazione AIRC per la ricerca sul cancro for this initiative!

Excited to announce our paper out today in Molecular Cell discovering a novel splicing factor GPATCH8 and its requirement for pathologic splicing activity of mutant SF3B1. With Robert K. Bradley & Sergei Doulatov. Led by Salima Benbarche, Jose Mario Pineda, & Laura Baquero Galvis: cell.com/molecular-cell…

Thank you for the opportunity to present our work on germline predisposition in this exciting meeting! #YERM #EHA2024

#EHA24 | Research on germline predisposition in myeloid neoplasms can significantly impact clinical practice. Martina Sarchi from Università di Pavia 👇🏼

LEGGENDE 🇮🇹🙌🏻🙌🏻🙌🏻 🥇 #ItaliaStatiUniti 🇮🇹🇺🇸 3-0 (25-18, 25-20, 25-17) #LaNazionale | CONI | ItaliaTeam | #Paris2024

Ready for #ASH24 🩸 Looking forward to presenting our work on preleukemic clonal evolution through iPSC reprogramming on Saturday: ash.confex.com/ash/2024/webpr… Università di Pavia Sergei Doulatov

🎉 I’m happy to share our latest work on clonal progression of SF3B1-mutant MDS. Check it out Blood Advances! 🩸 Thanks to Sergei Doulatov, Malcovati group Università di Pavia, all co-authors and Fondazione AIRC per la ricerca sul cancro for the support. ashpublications.org/bloodadvances/…

High-risk RUNX1 and STAG2, but not low-risk TET2, mutations selectively expand different compartments of SF3B1-mutant primitive HSPCs. ow.ly/uhFl50WfHnv #myeloidneoplasia